X-Square Capital’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-31,185
| Closed | -$53K | – | 166 |
|
|
2023
Q4 | $53K | Hold |
31,185
| – | – | 0.03% | 153 |
|
|
2023
Q3 | $36K | Hold |
31,185
| – | – | 0.02% | 137 |
|
|
2023
Q2 | $36K | Sell |
31,185
-116,677
| -79% | -$135K | 0.02% | 137 |
|
|
2023
Q1 | $223K | Hold |
147,862
| – | – | 0.13% | 131 |
|
|
2022
Q4 | $370K | Buy |
147,862
+95,000
| +180% | +$238K | 0.21% | 117 |
|
|
2022
Q3 | $223K | Hold |
52,862
| – | – | 0.14% | 130 |
|
|
2022
Q2 | $147K | Sell |
52,862
-500
| -0.9% | -$1.39K | 0.09% | 141 |
|
|
2022
Q1 | $305K | Hold |
53,362
| – | – | 0.16% | 125 |
|
|
2021
Q4 | $487K | Buy |
53,362
+100
| +0.2% | +$913 | 0.24% | 100 |
|
|
2021
Q3 | $569K | Sell |
53,262
-3,999
| -7% | -$42.7K | 0.29% | 88 |
|
|
2021
Q2 | $889K | Buy |
57,261
+41,462
| +262% | +$644K | 0.42% | 72 |
|
|
2021
Q1 | $256K | Buy |
15,799
+4,399
| +39% | +$71.3K | 0.12% | 103 |
|
|
2020
Q4 | $241K | Buy |
11,400
+1,400
| +14% | +$29.6K | 0.13% | 99 |
|
|
2020
Q3 | $148K | Hold |
10,000
| – | – | 0.11% | 91 |
|
|
2020
Q2 | $147K | Hold |
10,000
| – | – | 0.1% | 86 |
|
|
2020
Q1 | $117K | Buy |
+10,000
| New | +$117K | 0.12% | 74 |
|